Craft

Cognetivity Neurosciences

Stock Price

$0

2024-10-29

Market Capitalization

$895.9 K

2024-10-29

Revenue

$45 K

FY, 2023

Cognetivity Neurosciences Summary

Company Summary

Overview
Cognetivity Neurosciences is a medical technology company that develops a platform for early detection of cognitive impairment, dementia, and Alzheimer's disease. It uses artificial intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain. The technology aims at improving diagnosis rates.
Type
Public
Status
Active
Founded
2013
HQ
London, GB | view all locations
Website
https://www.cognetivity.com/
Cybersecurity rating
Sectors

Key People

LocationsView all

2 locations detected

  • London, England HQ

    United Kingdom

    3, Waterhouse Square, 138 - 142 Holborn

  • Vancouver, BC

    Canada

    1980-1075 W Georgia St

Cognetivity Neurosciences Financials

Summary Financials

Revenue (Q3, 2024)
$C29.0K
Gross profit (Q3, 2024)
$C29.0K
Net income (Q3, 2024)
($C2.0M)
Cash (Q3, 2024)
$C16.0K
EBIT (Q3, 2024)
($C1.8M)
Enterprise value
$2.2M

Footer menu